Click here to subscribe


 

Derma Sciences Featured on NJN News and WNET 13

Corporate Overview
Derma Sciences is a specialty medical device/pharmaceutical company dedicated to manufacturing, marketing, and selling a broad base of wound care products. The company focuses on three primary areas:
  1. Advanced Wound Care - Several newly-launched proprietary dressings along with a full line of products for chronic wounds and burns. Approximately 17% of current total revenue, expecting to grow to 28% of total revenue in 2010. This is our high-growth, high-margins area of concentration.
  2. Basic Wound Care - Includes both branded and private-label/OEM bandages, gauze-based dressings, wound closure strips, and first aid products. This is Derma's core business. Currently generating over 80% of current total revenue.
  3. Drug Development - Drug candidate DSC127 is in a Phase II study on Diabetic Foot Ulcer healing. Enrollment is expected to be completed within Q3 2010, with initial key efficacy results to be reported towards the end of Q4 2010.
Derma Sciences' products are marketed to wound care centers, long-term care facilities, hospitals, physicians' offices, clinics, home health care agencies and other health care institutions, as well as pharmacies on the retail side of the business. More >>>>
 
Key Documents 
 



Investor Relations Contact:
Kim Sutton Golodetz
Lippert/Heilshorn & Associates
(212) 838-3777
 
 

 
 
Latest News